XML 51 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT AND RELATED INFORMATION
12 Months Ended
Dec. 31, 2011
SEGMENT AND RELATED INFORMATION  
SEGMENT AND RELATED INFORMATION

NOTE O—SEGMENT AND RELATED INFORMATION

        The Company has identified three reportable segments in which it operates based on the products and services it provides. The Company evaluates segment performance and allocates resources based on the segments' income from operations. In December 2010, as a result of the acquisition of ACP, the Company realigned its reportable segments and identified the third operating segment. Therapeutic Solutions includes ACP and IN, Inc., which previously was included in Other. The results of IN, Inc. have been reclassified to Therapeutic Solutions in all years presented.

        The reportable segments are: (i) Patient-Care Services (ii) Distribution, and (iii) Therapeutic solutions. The reportable segments are described further below:

        Patient-Care Services—This segment consists of the Company's owned and operated patient-care centers and fabrication centers of O&P components. The patient-care centers provide services to design and fit O&P devices to patients. These centers also instruct patients in the use, care and maintenance of the devices. Fabrication centers are involved in the fabrication of O&P components for both the O&P industry and the Company's own patient-care centers. The principal reimbursement sources for the Company's services are:

  • Commercial and other, which consist of individuals, rehabilitation providers, private insurance companies, HMOs, PPOs, hospitals, vocational rehabilitation, workers' compensation programs and similar sources;

    Medicare, a federally funded health insurance program providing health insurance coverage for persons aged 65 or older and certain disabled persons, which provides reimbursement for O&P products and services based on prices set forth in fee schedules for 10 regional service areas;

    Medicaid, a health insurance program jointly funded by federal and state governments providing health insurance coverage for certain persons in financial need, regardless of age, which may supplement Medicare benefits for financially needy persons aged 65 or older; and

    U.S. Department of Veterans Affairs.

        The Company estimates that government reimbursement, comprised of Medicare, Medicaid and the U.S. Department of Veterans Affairs, in the aggregate, accounted for approximately 40.0%, 40.4%, and 40.5% of the Company's net sales in 2011, 2010, and 2009, respectively.

        Distribution—This segment distributes O&P products and components to both the O&P industry and the Company's own patient-care practices.

        Therapeutic Solutions—This segment consists of the leasing of rehabilitation equipment from, and the provision of clinical program by, ACP as well the operations of IN, Inc. ACP is a developer of specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation. IN, Inc. specializes in bringing emerging MyoOrthotics Technologies® to the O&P market. MyoOrthotics Technologies represents the merging of orthotic technologies with electrical stimulation.

        Other—This consists of Hanger corporate and Linkia. Linkia is a national managed-care agent for O&P services and a patient referral clearing house.

        The accounting policies of the segments are the same as those described in the summary of "Significant Accounting Policies" in Note B to the consolidated financial statements.

        Summarized financial information concerning the Company's reportable segments is shown in the following table. Intersegment sales mainly include sales of O&P components from the Distribution segment to the Patient-Care Services segment and were made at prices which approximate market values.

(In thousands)
  Patient-Care
Services
  Distribution   Therapeutic
Solutions
  Other   Consolidating
Adjustments
  Total  

2011

                                     

Net sales

                                     

Customers

  $ 753,409   $ 100,456   $ 64,014   $ 660   $   $ 918,539  

Intersegments

    15,853     174,431     3,520         (193,804 )    

Depreciation and amortization

    12,502     1,088     10,424     7,068     (113 )   30,969  

Income from operations

    139,790     28,293     3,703     (54,654 )   (305 )   116,827  

Interest (income) expense

    28,440     3,356     5,761     (5,736 )       31,821  

Income (loss) before taxes

    111,350     24,937     (2,058 )   (48,918 )   (305 )   85,006  

Total assets

   
1,279,481
   
170,077
   
135,781
   
(456,839

)
 
   
1,128,500
 

Capital expenditures

    11,886     1,318     3,667     11,253         28,124  

2010

                                     

Net sales

                                     

Customers

  $ 714,665   $ 95,544   $ 6,622   $ 548   $   $ 817,379  

Intersegments

        168,823     3,839         (172,662 )    

Depreciation and amortization

    11,211     1,004     1,293     5,414     (113 )   18,809  

Income from operations

    131,430     30,395     (5,402 )   (75,023 )   (21 )   81,379  

Interest (income) expense

    28,410     3,397     480     (1,947 )       30,340  

Income (loss) before taxes

    103,020     26,998     (5,882 )   (88,671 )   (21 )   35,444  

Total assets

   
1,054,270
   
146,166
   
142,970
   
(281,927

)
 
   
1,061,479
 

Capital expenditures

    17,599     1,112     2,056     9,826         30,593  

2009

                                     

Net sales

                                     

Customers

  $ 670,458   $ 88,043   $ 1,122   $ 447   $   $ 760,070  

Intersegments

        155,017     2,782         (157,799 )    

Depreciation and amortization

    10,288     893     349     4,902     (113 )   16,319  

Income from operations

    125,185     25,634     (5,762 )   (54,705 )   168     90,520  

Interest (income) expense

    28,470     3,443         (1,220 )       30,693  

Income (loss) before taxes

    96,715     22,191     (5,762 )   (53,318 )   168     59,994  

Total assets

   
821,988
   
119,989
   
(16,902

)
 
(50,039

)
 
   
875,036
 

Capital expenditures

    14,704     794     904     4,868         21,270  

        The Company's foreign and export sales and assets located outside of the United States of America are not significant. Additionally, no single customer accounted for more than 10% of revenues in 2011, 2010, or 2009.